Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma
- 1 January 2007
- journal article
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 48 (3), 570-576
- https://doi.org/10.1080/10428190601126610
Abstract
There is no consensus on the optimal chemotherapy regimen for Hodgkin's lymphoma patients > or = 60 years. We present our institution's results of 5 years, using CHOP-21 as standard for this patient group. Twenty-nine patients with a median age of 71 years (range, 60 - 91) were included in this cohort. Fifty-five percent had known co-morbidities. Stage I/IIA patients (38%) were treated with 2 - 4 cycles of CHOP followed by radiotherapy. Stage IIB - IV patients (62%) received 6 - 8 cycles of CHOP and for the majority (13/18 pts) no radiotherapy. Two treatment-related deaths occurred. Febrile neutropenia was the most common toxicity (31%). The complete response rate after CHOP +/- radiotherapy was 93%. With a median follow-up of 41 months, five patients have relapsed and four have died from Hodgkin's lymphoma. So far, no relapses have occurred after 2 years from the end of therapy. Overall survival and progression-free survival at 3 years were 79% and 76%, respectively. We conclude that CHOP-21 is a well-tolerated and effective treatment for elderly patients with Hodgkin's lymphoma.Keywords
This publication has 28 references indexed in Scilit:
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Epstein-Barr Virus As a Marker of Survival After Hodgkin's Lymphoma: A Population-Based StudyJournal of Clinical Oncology, 2005
- Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer RegistryEuropean Journal Of Cancer, 2005
- Hodgkin's Disease in the Elderly: Improved Treatment Outcome With a Doxorubicin-Containing RegimenJournal of Clinical Oncology, 2002
- Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II StudyLeukemia & Lymphoma, 2002
- Patients above Sixty Years Lymphoma Treated with a New Strategy of Age with Hodgkin'sActa Oncologica, 2002
- Long-term survival in Hodgkin's disease patients: a comparison of relative survival in patients in trials and those recorded in population-based cancer registriesEuropean Journal Of Cancer, 2000
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Outcome of Hodgkin's disease in elderly patientsHematological Oncology, 1995
- Hodgkin's disease and age*European Journal of Haematology, 1989